u/Beowein

Author argues DGXX trades at a major discount to its ~$100M liquidity fortress and controls 196.7 MW of active power capacity with a pathway to 1.3 GW, making it a replacement-cost arbitrage in an energy-constrained data-center market. The HPC pivot to NeoCloudz/ARMS 200 is framed as a free call option; if AI execution succeeds, the market could apply data-center multiples, while if it stalls the zero-debt balance sheet and steady energy sales supposedly provide a hard floor. The author cites a "Triple Catalyst" of liquidity confirmation, legal resolution, and capacity expansion, with 2026 as the horizon.

Spectral AI's DeepView uses discriminative AI on a proprietary 340-billion-datapoint wound database to predict burn healing with >80% accuracy on day one versus 60-70% for standard care, which can cut 14-21 day observation stays costing $3,000-$5,000/day. The stock trades as a distressed asset despite 18 months of runway, and the pending FDA De Novo decision (applied June 2025, likely Q1-early Q2 2026) is the central catalyst. Main stated risks are current financial optics/declining R&D revenue and potential FDA timeline extension.